(Total Views: 357)
Posted On: 08/26/2020 5:13:39 PM
Post# of 653
$RLFTF (copy) urgonnatrip DD - This part is interesting. May have already been mentioned, but it looks like only a little over a hundred of these have been granted since 2012 across the FDAs entire medical portfolio?
Quote:
RLF-100 has been granted Fast Track designation by FDA and is being developed as a Material Threat Medical Countermeasure in cooperation with the National Institutes of Health and other federal agencies. Further research will be conducted
FDA site notes these can be
Biologic products, such as vaccines, blood products and antibodies
Drugs, such as antimicrobial or antiviral drugs
Devices, including diagnostic tests to identify threat agents, and personal protective equipment (PPE), such as gloves, respirators (face masks), and ventilators
...and RLF is one of them.
Quote:
RLF-100 has been granted Fast Track designation by FDA and is being developed as a Material Threat Medical Countermeasure in cooperation with the National Institutes of Health and other federal agencies. Further research will be conducted
FDA site notes these can be
Biologic products, such as vaccines, blood products and antibodies
Drugs, such as antimicrobial or antiviral drugs
Devices, including diagnostic tests to identify threat agents, and personal protective equipment (PPE), such as gloves, respirators (face masks), and ventilators
...and RLF is one of them.
(0)
(0)
$MJ
